Published in Cardiovascular Business Week, April 13th, 2004
MSCs "have the potential to treat many myocardial diseases," scientists in the United States explained.
In their study, P.R. Vulliet and colleagues at the University of California-Davis "investigated whether these multipotent stem cells derived from bone marrow could be administered safely into the coronary circulation of healthy dogs."
"We injected about 0.5 million cells per kg bodyweight of early passage autologous MSCs into the left circumflex coronary artery of anaesthetized dogs," according to the report. "During...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.